Gemcitabine
Links shared publicly online about this topic
Oncology Article | Gemcitabine
mdlinx.com — “A novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC--MS/MS: comparison with 19F NMR spectroscopy” View full resource at mdlinx.com
Most Recently Shared on April 15, 2011 at 3:43 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and ge... http://bit.ly/fwpIMG #oncology
Oncology Medical News about Gemcitabine
mdlinx.com — “Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF” View full resource at mdlinx.com
Most Recently Shared on May 20, 2010 at 8:12 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-2... http://bit.ly/bqc2Gx #oncology
ingentaconnect Gemcitabine: Acute eosinophilic pneumonia in an elderly patient: ...
ingentaconnect.com — “ingentaconnect Gemcitabine: Acute eosinophilic pneumonia in an elderly patient: ...” View full resource at ingentaconnect.com
Most Recently Shared on September 21, 2010 at 4:36 pm By:
Gemcitabine: Acute eosinophilic pneumonia in an elderly patient: case report: (Source: Reactions)MedWorm Message: ... http://bit.ly/duyUd0
ASCO: Radioimmunotherapy + gemcitabine shows promise for pancreatic cancer
healthimaging.com — “The results of an ongoing phase I/II study for treating advanced pancreatic cancer with a combination therapy of Immunomedics' antibody, clivatuzumab tetraxetan, (90Y-hPAM4) and anticancer drug gemcitabine, which demonstrated therapeutic activity at two 90Y dose levels with minimal hematologic toxicity, was presented with positive findings at the seventh annual Gastrointestinal Cancers Symposium in Orlando, Fla. this week.” View full resource at healthimaging.com
Most Recently Shared on January 28, 2010 at 2:22 pm By:
Health Imaging & IT Health Magazine
ASCO: Radioimmunotherapy + gemcitabine shows promise for pancreatic cancer http://ow.ly/16rvem
Nab-Paclitaxel Plus Gemcitabine Shows Promise In Advanced Pancreatic Cancer
medicalnewstoday.com — “Washington - A combination of nab-paclitaxel (AbraxaneR for Injectable Suspension) and gemcitabine improves survival when used as first-line treatment in patients with advanced pancrea” View full resource at medicalnewstoday.com
Most Recently Shared on April 23, 2010 at 2:28 pm By:
Nab-Paclitaxel Plus Gemcitabine Shows Promise In Advanced Pancreatic Cancer http://mnt.to/3BFg #cancer
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study : The Lancet Oncology
thelancet.com — “Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study. By - Dr Hedy L Kindler MD, Tatsuya Ioka MD, D...” View full resource at thelancet.com
Most Recently Shared on February 8, 2011 at 3:48 pm By:
Reporting a phase 3 trial of gemcitabine plus axitinib in patients with advanced pancreatic cancer. http://fb.thelancet.com/JLh
Oncology Article | Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells
mdlinx.com — “Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells” View full resource at mdlinx.com
Most Recently Shared on October 31, 2011 at 9:43 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells: Cancer Letters http://t.co/f7H7Q2EY #oncology
ingentaconnect Erlotinib Resistance is Altered after Gemcitabine Chemotherapy fo...
ingentaconnect.com — “ingentaconnect Erlotinib Resistance is Altered after Gemcitabine Chemotherapy fo...” View full resource at ingentaconnect.com
Most Recently Shared on March 10, 2011 at 5:33 am By:
Erlotinib Resistance is Altered after Gemcitabine Chemotherapy for Recurrent Non-Small-Cell Lung Cancer: (Source... http://bit.ly/dOaavm
ingentaconnect Gemcitabine: Interstitial pneumonia in an elderly patient: case r...
ingentaconnect.com — “ingentaconnect Gemcitabine: Interstitial pneumonia in an elderly patient: case r...” View full resource at ingentaconnect.com
Most Recently Shared on August 11, 2011 at 6:11 pm By:
Gemcitabine: Interstitial pneumonia in an elderly patient: case report: (Source: Reactions) http://bit.ly/p3c0c3
Low-Dose Radiation Boosts Effect of Gemcitabine in Pancreatic Cancer | Radiology
medicexchange.com — “Combining low-dose fractionated radiation therapy with gemcitabine (Gemzar) might potentiate the effect of gemcitabine, but with lower toxicity, in patients with advanced pancreatic cancer.” View full resource at medicexchange.com
Most Recently Shared on November 12, 2010 at 9:55 am By:
Alex van Klaveren Health Social Media
Low-Dose Radiation Boosts Effect of Gemcitabine in Pancreatic Cancer: Combining low-dose fractionated radiation ... http://bit.ly/cXNDNA
Low-Dose Radiation Boosts Effect of Gemcitabine in Pancreatic Cancer | Radiology
medicexchange.com — “Combining low-dose fractionated radiation therapy with gemcitabine (Gemzar) might potentiate the effect of gemcitabine, but with lower toxicity, in patients with advanced pancreatic cancer.” View full resource at medicexchange.com
Most Recently Shared on November 12, 2010 at 9:55 am By:
Alex van Klaveren Health Social Media
Latest News- Low-Dose Radiation Boosts Effect of Gemcitabine in Pancreatic Cancer http://bit.ly/b6CY7B #radiology #healthit
Researchers identify critical marker of response to gemcitabine in pancreatic cancer
physorg.com — “A protein related to aggressive cancers can actually improve the efficacy of gemcitabine at treating pancreatic cancer, according to a Priority Report in Cancer Research, published by researchers at Thomas Jefferson University.” View full resource at physorg.com
Most Recently Shared on June 4, 2009 at 3:22 pm By:
Researchers identify critical marker of response to gemcitabine in pancreatic cancer http://tinyurl.com/o2bgnw
Researchers Identify Critical Marker of Response to Gemcitabine in Pancreatic Cancer
newswise.com — “A protein related to aggressive cancers can actually improve the efficacy of gemcitabine at treating pancreatic cancer, according to a Priority Report in Cancer Research, published by researchers at Thomas Jefferson University.” View full resource at newswise.com
Most Recently Shared on June 4, 2009 at 4:25 pm By:
Researchers Identify Critical Marker of Response to Gemcitabine in Pancreatic Cancer http://bit.ly/4Em0Bq
Combination of gemcitabine and cisplatin limits the progression of endometrial cancer: Study
buzzup.com — “Researchers from The University of Texas M. D. Anderson Cancer Center report that in a small study of women with advanced or recurrent endometrial cancer, gemcitabine and cisplatin, when used in combination, produced a response rate in fifty percent of patients.” View full resource at buzzup.com
Most Recently Shared on March 18, 2010 at 12:25 pm By:
Ovarian Cancer News: Combination of gemcitabine and cisplatin limits the progression of endometrial cancer: Stu... http://buzzup.com/qrlm_
Gemcitabine May Hold Promise for BCG Failures - Renal and Urology News
renalandurologynews.com — “Gemcitabine might be a second-line treatment option for patients with high-risk non-muscle-invasive bladder cancer (BC) who fail therapy with bacille Calmette-Gurin (BCG), according to Italian researchers.” View full resource at renalandurologynews.com
Most Recently Shared on March 30, 2010 at 5:14 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
Gemcitabine May Hold Promise for BCG Failures: Gemcitabine might be a second-line treatment option for patients wi... http://bit.ly/cOMQcN
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Lungs and Breathing
Organizing lung and breathing resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
